Tests for the immune response to the coronavirus are revealing thousands of people who were infected but never got severely ill. The findings suggest the virus is less deadly than it first appeared.
Full story of excerpts below at Source: >Coronavirus Antibody Testing Shows Lower Fatality Rate For Infection : Shots – Health News : NPR
Mounting evidence suggests the coronavirus is more common and less deadly than it first appeared. The evidence comes from tests that detect antibodies to the coronavirus in a person’s blood rather than the virus itself.
The tests are finding large numbers of people in the U.S. who were infected but never became seriously ill. And when these mild infections are included in coronavirus statistics, the virus appears less dangerous. …But even a virus with a fatality rate less than 1% presents a formidable threat.
“That is many times more deadly than seasonal influenza,” ….Studies suggest a healthy young person’s chance of dying from an infection is less than 1 in 1,000. But for someone in poor health in their 90s, it can be greater than 1 in 10...And that means different states in the U.S. should expect different infection fatality rates.
(Video) “COVID-19 Update 54 with critical care specialist Roger Seheult, MD of https://www.MedCram.com Production of COVID-19 antibody test kits are ramping up – there are over 70 companies producing them. Antibody tests could be one of the keys to eventually easing social distancing restrictions and allowing schools and businesses to re-open. Unfortunately, only one antibody test is FDA approved at this time, and the approval of each company will take some time. Dr. Seheult illustrates how antibody tests and PCR-RT tests for COVID-19 work on the cellular level, and he discusses potential coronavirus vaccine challenges.”
“Stanford is testing for coronavirus antibodies so they can determine who has been exposed and who could potentially go back to school or work. NPR’s Lulu Garcia-Navarro speaks to Dr. Jay Bhattacharya.LULU GARCIA-NAVARRO,
“HOST:The only way we’ll truly get a hold of this pandemic and come out the other side is through science – ultimately with a vaccine, but in the meantime through testing. There are tests that determine if someone who is sick has COVID-19 by taking nasal swabs, but also important is something called antibody or serological tests. And one of the places that’s doing that is Stanford University. Joining us now is Dr. Jay Bhattacharya, professor of medicine at Stanford University, who is part of this study:
Listen to 5 minute podcast and read full interview at Source: >How Antibody Tests Can Inform Public Policies To Mitigate Coronavirus Pandemic : NPR